morpholino
oligonucleotid
stabl
uncharg
watersolubl
molecul
use
block
complementari
sequenc
rna
prevent
process
readthrough
protein
bind
site
morpholino
typic
use
block
translat
mrna
block
splice
premrna
though
block
interact
biolog
macromolecul
rna
morpholino
effect
specif
lack
nonantisens
effect
work
cell
transcrib
translat
rna
must
deliv
nuclearcytosol
compart
effect
morpholino
form
stabl
base
pair
complementari
nucleic
acid
sequenc
appar
bind
protein
signific
extent
recogn
protein
undergo
proteinmedi
catalysisnor
mediat
rna
cleavag
rnase
h
risc
complex
work
focus
techniqu
background
use
morpholino
c
john
wiley
son
inc
keyword
morpholino
r
antisens
r
oligo
r
knockdown
r
splice
morpholino
oligo
morpholino
synthet
uncharg
pchiral
analog
nucleic
acid
typic
construct
link
togeth
subunit
bear
nucleic
acid
base
figur
illustr
structur
three
morpholino
subunit
join
intersubunit
linkag
morpholino
phosphorodiamid
backbon
morpholino
consist
morpholin
ring
bear
methylen
group
bound
modifi
phosphat
anion
oxygen
replac
nonion
dimethylamino
group
substitut
phosphat
bound
phosphorusnitrogen
bond
nitrogen
atom
anoth
morpholin
ring
one
standard
dna
nucleobas
adenin
guanin
cytosin
thymin
bound
morpholin
ring
end
morpholino
convent
name
analog
nomenclatur
nucleic
acid
though
one
number
atom
morpholino
oligonucleotid
backbon
iupac
rule
number
assign
end
would
differ
secondari
amin
morpholin
ring
end
unmodifi
morpholino
oligonucleotid
call
end
oligo
wherea
end
termin
carboxamid
phosphorodiamid
group
fig
antisens
morpholino
block
interact
macromolecul
mrna
base
pair
target
mrna
complementari
fashion
thu
prevent
initi
complex
readthrough
modif
splice
cell
rang
bacteri
geller
et
al
human
suwanmane
et
al
particular
antisens
morpholino
becom
standard
tool
development
biologist
manipul
gene
express
embryo
zebrafish
xenopu
sp
ekker
larson
modifi
oligonucleotid
combin
efficaci
specif
stabil
lack
nonantisens
effect
good
watersolubl
properti
morpholino
origin
conceiv
jame
e
summerton
molecul
intend
human
therapeut
summerton
first
compani
found
call
sarepta
therapeut
inc
success
brought
first
approv
morpholino
drug
clinic
trial
receiv
acceler
approv
us
fda
market
drug
fda
drug
call
eteplirsen
exondi
morpholino
oligo
target
exon
common
human
dystrophin
transcript
isoform
peopl
duchenn
muscular
dystrophi
dmd
frameshift
mutat
caus
exon
remov
matur
mrna
skip
exon
restor
read
frame
dystrophin
intern
truncat
protein
produc
predict
benefit
dmd
popul
mendel
et
al
small
amount
standard
morpholino
oligo
enter
dystroph
muscl
use
enter
wildtyp
muscl
show
standard
morpholino
oligo
dmd
especi
amen
treatment
deliveri
barrier
need
overcom
perhap
conjug
morpholino
deliveri
moieti
appli
oligo
effect
treatment
mani
diseas
moulton
moulton
unit
present
three
protocol
design
knockdown
experi
use
morpholino
basic
protocol
prepar
morpholino
solut
basic
protocol
introduct
morpholino
cell
endocytosi
presenc
amphiphil
peptid
basic
protocol
commentari
provid
thorough
discuss
condit
consider
applic
morpholino
choos
cell
organ
oligo
deliv
choos
sort
target
process
typic
block
translat
modifi
splice
target
process
may
chosen
inhibit
mirna
matur
block
poli
tail
block
rna
transloc
choic
target
process
determin
molecular
assay
avail
measur
antisens
activ
obtain
sequenc
target
rna
use
mrna
utr
first
code
base
translat
blocker
premrna
intron
exon
defin
splice
blocker
choos
deliveri
method
select
control
oligo
decid
whether
endmodif
oligo
necessari
block
splice
select
premrna
splice
junction
intronexon
exonintron
block
wish
caus
frameshift
possibl
activ
nonsensemedi
decay
influenc
choic
splice
junction
select
oligo
target
follow
target
rule
describ
commentari
produc
optim
morpholino
sequenc
invers
complement
target
use
transcript
databas
homolog
search
tool
blast
test
select
target
homolog
rna
submicromolar
concentr
lose
signific
activ
bind
glass
plastic
surfac
strongli
recommend
morpholino
stock
solut
made
distil
water
isoton
buffer
eg
ringer
solut
danieau
buffer
also
use
use
distil
water
facilit
process
concentr
morpholino
measur
mass
malditof
mass
spectrometri
either
process
requir
water
must
treat
diethylpyrocarbon
depc
import
autoclav
treat
water
destroy
residu
depc
use
dissolv
morpholino
otherwis
depc
react
adenin
compromis
abil
morpholino
bind
target
henderson
et
al
pipet
hcl
quartz
cell
place
cell
spectrophotomet
blank
spectrophotomet
nm
remov
cell
spectrophotomet
pipet
aqueou
morpholino
solut
quartz
cell
like
natur
nucleic
acid
nucleobas
morpholino
stack
produc
hypochrom
effect
without
unstack
base
use
molar
absorpt
individu
nucleobas
calcul
concentr
oligo
would
lead
erron
low
valu
oligo
c
g
base
unstack
dissolv
oligo
hcl
condit
c
g
base
proton
stack
state
due
electrostat
repuls
nucleobas
oligo
unstack
molar
absorpt
nucleobas
appli
determin
concentr
oligo
absorb
outsid
spectrophotomet
linear
respons
rang
dilut
solut
repeat
measur
adjust
dilut
factor
step
account
chang
calcul
molar
concentr
c
origin
morpholino
solut
factor
dilut
hcl
molar
absorpt
b
path
length
cell
cm
molar
absorpt
morpholino
provid
product
inform
sheet
altern
calcul
multipli
molar
absorpt
nucleobas
c
g
number
instanc
nucleobas
present
oligo
ad
product
pathlength
spectromet
beer
law
calcul
work
absorb
relationship
absorb
concentr
linear
measur
absorb
sampl
dilut
remeasur
endoport
amphiphil
peptid
coendocytosi
morpholino
endoport
permeabil
membran
acid
endosom
releas
morpholino
endosom
cytosol
summerton
endoport
optim
use
hela
cell
line
toler
cell
type
toward
endoport
often
vari
rang
endoport
concentr
test
begin
knockdown
experi
dmso
formul
typic
severalfold
effect
aqueou
formul
observ
cell
hr
deliveri
determin
cellular
toxic
adher
cell
look
morpholog
chang
draw
extend
process
caus
cell
becom
rounderfor
mani
cell
type
chang
shape
indic
toxic
subsequ
morpholino
deliveri
select
cell
type
use
concentr
endoport
gave
best
deliveri
without
toxic
deliv
morpholino
cell
use
cell
cultur
previous
expos
endoport
replac
spent
cultur
medium
fresh
medium
serum
morpholino
phosphorodiamid
backbon
morpholino
oligo
signific
ionic
charg
neutral
ph
contrast
polyanion
phosphodiest
backbon
natur
nucleic
acid
favor
interact
morpholino
nucleic
acid
sinc
repuls
anion
backbon
duplex
natur
nucleic
acid
dissolv
pure
water
nucleic
acid
lose
abil
form
stabl
watsoncrick
bond
due
anion
repuls
strand
wherea
morpholino
still
bind
complementari
sequenc
summerton
morpholino
uncharg
strong
electrostat
interact
protein
unmodifi
morpholino
littl
affin
bovin
human
serum
albumin
assess
surfac
plasmon
reson
spectroscopi
hm
moulton
unpub
observ
contrast
interact
anion
phosphorothio
oligo
protein
caus
multipl
physiolog
nonantisens
effect
lebedeva
stein
protein
bind
nucleic
acid
gener
interact
electrostat
anion
phosphat
nucleic
acid
stabil
bind
morpholino
appear
littl
interact
nucleic
acidbind
protein
hudziak
et
al
synthesi
subunit
assembl
solidphas
resin
describ
modifi
synthesi
protocol
offer
alter
protect
group
activ
scheme
publish
bhadra
et
al
morpholino
stabl
nucleolyt
enzym
known
enzym
degrad
morpholino
specif
morpholino
expos
rang
nucleas
eg
dnase
dnase
ii
benzonas
nucleas
mung
bean
nucleas
bal
nucleas
rnase
rnase
phosphodiesteras
phosphodiesteras
ii
proteas
eg
pronas
e
proteinas
k
pig
liver
esteras
condit
lytic
enzym
would
degrad
substrat
case
degrad
morpholino
detect
hudziak
et
al
morpholino
incub
serum
liver
homogen
without
peptidemorpholino
conjug
extract
cell
analyz
malditof
mass
spectrometri
morpholino
oligo
compon
degrad
cell
although
rang
degrad
product
peptid
moieti
detect
youngblood
et
al
crystal
structur
highresolut
nmr
structur
analysi
phosphorodiamid
morpholino
publish
howev
studi
morpholino
phosphorodiamid
apa
dimer
use
circular
dichroic
spectroscopi
show
stack
base
aqueou
phosphat
buffer
kang
et
al
basi
molecular
model
base
morpholino
stack
fashion
analog
natur
nucleic
acid
allow
strong
interact
complementari
nucleic
acid
sequenc
watsoncrick
base
pair
mhz
h
nmr
analysi
carbamatelink
nucleic
acid
analog
use
morpholin
ring
instead
sugar
found
morpholin
ring
chair
conform
stirchak
et
al
molecular
model
morpholino
morpholin
ring
chair
conform
suggest
morpholino
rna
form
aform
heteroduplex
helic
pitch
similar
aform
rnarna
duplex
je
summerton
unpub
observ
variou
type
antisens
oligo
rank
affin
bind
singl
strand
sens
rna
base
dissoci
temperatur
physiolog
salt
buffer
tabl
stein
et
al
affin
rna
rna
greater
affin
morpholino
rna
howev
singl
strand
mrna
fold
secondari
structur
contain
singlestrand
region
loop
stemloop
morpholino
readili
hybrid
given
doublestrand
region
rna
secondari
structur
shorter
base
pair
overal
bind
affin
morpholino
rna
suffici
invad
displac
short
doublestrand
region
summerton
antisens
oligo
dna
phosphorothio
sdna
oligo
recruit
rnase
h
degrad
mrna
target
summerton
rnai
sirna
also
employ
antisens
mechan
recogn
sens
mrna
interact
risc
lead
enzymat
degrad
complementari
mrna
translat
block
partial
complementari
mrna
scacheri
et
al
contrast
instead
degrad
mrna
antisens
morpholino
design
block
translat
mrna
protein
figur
compar
steric
block
rnase
hdepend
riscdepend
oligo
compar
rnase
hdepend
oligo
methylphosphon
diester
phosphodiest
chimera
morpholino
cpgnnn
motif
shown
induc
apoptosi
cell
cycl
arrest
present
rnase
hdepend
oligo
present
morpholino
tidd
et
al
report
morpholino
induc
either
interferon
product
induct
mediat
inflamm
morpholino
contain
cpg
motif
stimul
immun
respons
je
summerton
krieg
unpub
observ
suggest
morpholinorna
heteroduplex
stimul
tolllik
receptor
morpholino
complementari
sequenc
utr
first
code
base
mrna
halt
progress
initi
complex
toward
start
codon
prevent
assembl
entir
ribosom
inhibit
translat
mrna
sequenc
polypeptid
morpholino
target
entir
downstream
start
codon
usual
ineffect
block
translat
summerton
addit
applic
knock
gene
express
stericblock
oligo
trigger
degrad
rna
morpholino
also
wide
use
block
splice
premrna
splice
eukaryot
direct
snrnp
bind
intron
mark
intronexon
boundari
morpholino
target
snrnpbind
site
modifi
splice
sazani
et
al
either
prevent
splice
caus
intron
inclus
gile
et
al
redirect
splice
caus
exon
excis
draper
et
al
block
splice
site
caus
activ
cryptic
splice
site
complic
interpret
splice
modif
produc
partial
delet
exon
draper
et
al
partial
inclus
intron
case
singl
morpholino
caus
skip
sever
adjac
exon
morpholino
stimul
sitespecif
ribosom
frameshift
bound
downstream
shift
site
mrna
far
higher
effici
rna
phosphorothio
oligo
omethyl
rna
oligo
howard
et
al
although
morpholino
often
use
block
translat
initi
complex
snrnp
direct
splice
mrna
sequenc
attract
target
steric
block
specif
morpholino
block
mirna
activ
bind
preprimirna
inhibit
matur
bind
mirna
prevent
bind
mrna
target
kloosterman
et
al
bind
site
mrna
mirna
would
otherwis
bind
choi
et
al
along
similar
line
morpholino
target
across
cleavag
site
hammerhead
ribozym
inhibit
autocleavag
lead
greater
two
order
magnitud
increas
express
downstream
report
gene
yen
et
al
morpholino
also
shown
block
intron
splice
silenc
bruno
et
al
exon
splice
enhanc
mcclorey
et
al
redirect
splice
morpholino
bind
poli
signal
sequenc
inhibit
poli
tail
wada
et
al
morpholino
bind
transloc
sequenc
inhibit
direct
movement
rna
within
cell
arthur
et
al
morpholino
commonli
microinject
embryo
singlecel
fewcel
stage
block
gene
involv
develop
heasman
et
al
naseviciu
ekker
nutt
et
al
morpholino
also
commonli
use
cell
cultur
tysoncapp
europefinn
applic
intact
adult
organ
recent
limit
poor
vivo
deliveri
cytosol
cell
summerton
sazani
et
al
howev
advanc
conjug
morpholino
cellpenetr
peptid
nelson
et
al
octaguanidinium
dendrim
form
vivomorpholino
allow
effect
system
deliveri
adult
organ
alonso
et
al
kinney
et
al
neuman
et
al
enterlein
et
al
combin
sever
oligonucleotid
sequenc
bind
sever
differ
rna
target
simultan
introduc
togeth
embryo
ekker
cell
cultur
summerton
allow
multipl
knockdown
synergist
target
singl
messeng
target
viral
rna
morpholino
report
hepat
c
jubin
et
al
mccaffrey
et
al
dengu
viru
kinney
et
al
ebola
viru
enterlein
et
al
warfield
et
al
sar
viru
neuman
et
al
west
nile
viru
dea
et
al
equin
arteriviru
van
den
born
et
al
mous
hepat
viru
neuman
et
al
novirhabdoviru
alonso
et
al
vesiviru
addit
translat
start
site
success
target
inhibit
viral
replic
includ
cycliz
sequenc
dea
et
al
termin
stem
loop
dea
et
al
intern
ribosom
entri
site
ire
jubin
et
al
radioisotop
deliveri
organ
pretarget
use
morpholino
mangera
et
al
practition
nuclear
medicin
strive
minim
radiat
exposur
patient
deliv
radionuclid
target
tissu
imag
therapeut
applic
attach
radioisotop
antibodi
specif
target
tissu
antibodi
anchor
isotop
tissu
larg
antibodi
molecul
diffus
slowli
isotop
must
maintain
plasma
high
concentr
long
durat
achiev
good
deliveri
radioisotopelink
antibodi
target
pretarget
morpholino
involv
introduc
antibodymorpholino
conjug
bloodstream
done
use
high
concentr
redos
satur
target
without
expos
patient
radiat
pretarget
stage
next
conjug
radioisotop
possibl
chelat
complementari
morpholino
ad
blood
morpholino
much
smaller
molecular
mass
antibodi
radionuclidemorpholino
conjug
diffus
rel
quickli
captur
target
tissu
rapidli
morpholinomorpholino
pair
unbound
radionuclidemorpholino
conjug
rapidli
elimin
kidney
techniqu
allow
deliveri
radioisotop
target
tissu
expos
organ
lower
dose
radiat
away
target
region
process
develop
techniqu
pharmacokinet
morpholinoradionuclid
conjug
studi
vivo
liu
et
al
b
et
al
recent
modif
signal
amplifi
bind
polym
bear
mani
complementari
morpholino
morpholinoconjug
antibodi
fragment
follow
deliv
radioisotopelabel
morpholino
complementari
polymerlink
morpholino
et
al
et
al
cellsurfac
membran
protein
concentr
small
region
plasma
membran
bind
morpholinoconjug
antibodi
expos
cell
polym
particl
bear
complementari
morpholino
chu
et
al
paramet
consid
select
oligonucleotid
target
sequenc
includ
cg
g
selfcomplementar
tetrag
moieti
length
oligo
intend
temperatur
oligo
use
target
recommend
summar
tabl
rang
cg
consid
ideal
morpholino
system
oligo
cg
may
lack
affin
need
effect
steric
block
oligo
cg
like
interact
offtarget
messeng
highaffin
subsequ
howev
predict
reliabl
predictor
morpholino
activ
mostli
supplant
use
cg
content
design
criterion
collabor
dna
softwar
gene
tool
llc
complementari
morpholinorna
heteroduplex
melt
paramet
measur
algorithm
develop
calcul
predict
duplex
base
morpholino
sequenc
hypothes
test
iter
process
new
oligo
sequenc
could
predict
accept
accuraci
dna
softwar
make
algorithm
avail
oligo
design
softwar
packag
gene
tool
typic
prefer
oligo
predict
oligo
g
content
affect
aqueou
solubl
oligo
higher
g
content
less
solubl
particularli
oligo
dissolv
isoton
salt
solut
morpholino
g
content
solubl
millimolar
rang
pure
water
aqueou
buffer
howev
chill
especi
freezethaw
cycl
caus
highg
oligo
precipit
associ
contain
wall
recoveri
oligo
solut
difficult
imposs
see
basic
protocol
selfcomplementari
sequenc
caus
either
intramolecular
interact
form
stemloop
intermolecular
interact
form
dimer
morpholino
short
sequenc
one
part
oligo
complementari
anoth
short
sequenc
separ
interven
sequenc
stemloop
form
small
selfcomplementari
sequenc
separ
zero
base
format
stabl
stemloop
unlik
hairpin
small
loop
energet
favor
prevent
loss
oligo
activ
competit
selfpair
target
bind
prudent
limit
selfcomplementari
sequenc
oligo
design
contigu
hydrogen
bond
less
cg
pair
contribut
three
hydrogen
bond
pair
contribut
two
hydrogen
bond
instanc
short
sequenc
atggc
gccat
form
contigu
hydrogen
bond
analyz
sequenc
selfcomplementar
check
watsoncrick
basepair
gt
basepair
like
pair
gt
pair
also
form
two
hydrogen
bond
howev
overal
stabil
gt
pair
far
lower
pair
gt
pair
score
singl
hydrogen
bond
calcul
contribut
stabil
selfcomplementari
moieti
aboulela
et
al
oligo
contain
selfcomplementari
sequenc
form
dimer
prevent
loss
oligo
activ
competit
dimer
format
target
bind
prudent
limit
complementari
palindrom
contigu
hydrogen
bond
less
instanc
two
oligo
bear
selfcomplementari
sequenc
atgcatgcgt
encount
form
contigu
hydrogen
bond
take
account
gt
pair
would
like
poor
antisens
activ
nucleic
acid
contain
gggg
moieti
interact
hoogsteen
bond
form
oligo
tetram
cheong
moor
morpholino
contain
g
tetrad
reduc
activ
like
mechan
contigu
stretch
four
g
base
avoid
design
morpholino
minimum
inhibitori
length
mil
antisens
oligo
length
need
achiev
reduct
translat
target
gene
concentr
typic
achiev
cell
mil
morpholino
vari
somewhat
target
averag
base
cell
cultur
summerton
ensur
good
affin
morpholino
rna
target
oligo
usual
synthes
influenc
mil
oligo
highert
oligo
shorter
mil
oligo
high
might
interact
offtarget
rna
oligo
shorten
base
lessen
likelihood
offtarget
interact
decreas
process
margin
loss
affin
result
shorten
hight
oligo
produc
accept
ruin
activ
slightli
improv
specif
effect
way
improv
specif
choos
target
produc
oligo
accept
though
possibl
transcript
target
guidelin
develop
oligo
use
mani
embryo
grown
lower
temperatur
temperatur
decreas
appreci
stabil
basepair
increas
ideal
oligo
design
use
lower
temperatur
would
expect
lower
oligo
recommend
system
practic
howev
rang
perform
well
colder
system
eg
zebrafish
frog
allow
number
base
pair
selfcomplementari
sequenc
might
prudent
reduc
colder
system
solubl
also
decreas
lower
temperatur
best
select
oligo
lower
g
content
use
colder
system
block
translat
morpholino
target
anywher
cap
nucleotid
code
sequenc
target
extend
downstream
code
sequenc
long
translat
start
codon
cover
first
step
translat
initi
complex
form
cap
scan
utr
start
codon
fig
start
codon
larg
ribosom
subunit
bind
initi
factor
dissoci
translat
proce
code
region
morpholino
get
way
initi
complex
initi
complex
reach
start
codon
prevent
assembl
ribosom
translat
mrna
nonetheless
prefer
target
start
codon
instead
upstream
two
reason
first
qualiti
sequenc
deposit
public
databas
poor
utr
especi
older
sequenc
record
second
though
rare
vertebr
genom
intern
ribosom
entri
site
ire
exist
allow
ribosom
enter
assembl
downstream
morpholino
bound
utr
block
splice
morpholino
typic
target
premrna
across
adjac
boundari
exon
intron
premrna
undergo
splice
two
flank
exon
first
last
exon
arbitrari
number
intern
exon
first
exon
singl
splice
site
splice
donor
contact
intron
intern
exon
two
junction
splice
acceptor
upstream
end
splice
donor
downstream
end
last
exon
splice
acceptor
upstream
end
target
splice
site
intern
exon
usual
caus
exon
excis
result
mrna
miss
exon
block
splice
site
fig
target
splice
site
flank
first
last
exon
usual
caus
intron
inclus
result
mrna
contain
first
last
intron
intron
inclus
also
occur
target
intern
exon
though
less
frequent
observ
occur
intron
oligo
bind
includ
matur
mrna
sometim
block
splice
site
activ
cryptic
splice
site
trigger
doubl
exon
skip
result
mrna
unexpect
mass
snrnp
direct
splice
bind
intron
side
splice
junction
morpholino
chosen
complementari
intron
sequenc
exon
sequenc
morpholino
good
activ
target
entir
intron
sequenc
near
splice
junction
activ
decreas
target
move
farther
intron
morco
splice
also
modifi
prevent
excis
arbitrari
intron
block
nucleophil
adenosin
close
splice
lariat
pa
morco
unpub
observ
target
spliceregulatori
sequenc
often
goal
spliceblock
experi
elimin
activ
protein
use
techniqu
elimin
upstream
exon
number
base
evenli
divis
three
caus
downstream
translat
frameshift
activ
site
protein
known
straightforward
strategi
target
morpholino
exon
encod
activ
site
caus
loss
exon
activ
site
anoth
trigger
inclus
first
intron
especi
use
contain
infram
stop
codon
number
nucleotid
evenli
divis
three
sometim
caus
random
exon
exclus
intron
inclus
suffici
elimin
activ
protein
perhap
due
result
chang
protein
tertiari
structur
sinc
mismatch
serious
decreas
activ
morpholino
qualiti
target
sequenc
import
consider
design
morpholino
sometim
error
sequenc
databas
file
variat
sequenc
strain
organ
also
present
problem
definit
way
ensur
correct
target
sequenc
sequenc
target
gene
strain
use
experi
morpholino
use
near
lowest
effect
concentr
effect
specif
compar
knockdown
technolog
condit
oligo
also
interact
sequenc
contain
one
two
mismatch
compar
oligo
perfectli
complementari
target
although
even
singl
mismatch
decreas
activ
khokha
et
al
howev
sequenc
expect
occur
randomli
base
pool
size
morpholinotarget
site
human
transcriptom
summerton
concentr
antisens
oligo
increas
well
minimum
effect
concentr
interact
target
contain
mismatch
concentr
morpholino
begin
alter
express
offtarget
mrna
therefor
import
oligo
concentr
kept
low
practic
still
elicit
desir
chang
gene
express
concentr
offtarget
effect
occur
concentr
target
knockdown
occur
ratio
concentr
sequencespecif
unknown
new
oligo
sequenc
case
effect
specif
concentr
window
exist
complementari
mrna
offtarget
mispair
mrna
similar
concentr
onset
target
knockdown
occur
lower
concentr
onset
offtarget
knockdown
howev
knock
highcopynumb
mrna
requir
higher
oligo
concentr
increas
probabl
knock
lowcopynumb
offtarget
mrna
situat
narrow
even
close
effect
specif
concentr
window
singl
mismatch
morpholino
may
caus
signific
decreas
antisens
activ
khokha
et
al
though
mani
singlemismatch
oligo
retain
good
activ
use
near
concentr
perfectli
complementari
morpholino
elicit
knockdown
five
mismatch
distribut
throughout
usual
decreas
activ
mismatch
oligo
near
undetect
level
st
knuth
unpub
observ
prudent
check
target
sequenc
propos
oligo
nucleotid
sequenc
databas
order
identifi
region
morpholino
might
bind
offtarget
mrna
search
homolog
target
keep
mind
morpholino
block
translat
target
utr
first
base
code
sequenc
morpholino
modifi
splice
target
intron
near
intronexon
boundari
morpholino
homolog
offtarget
mrna
outsid
limit
region
bind
oligo
mrna
like
affect
express
offtarget
mrna
though
block
mirna
target
regulatori
sequenc
exon
splice
enhanc
may
affect
express
compar
morpholino
nearli
complementari
offtarget
rna
sequenc
region
morpholino
might
biolog
effect
fraction
homolog
base
alway
howev
percentag
ignor
import
consider
distribut
mismatch
throughout
oligo
contigu
base
homolog
minimum
inactiv
length
morpholino
summerton
howev
base
perfect
homolog
flank
mismatch
either
side
run
homolog
base
beyond
flank
singl
mismatch
oligo
may
still
bind
suffici
block
translat
splice
high
cg
content
make
shorter
homolog
sequenc
activ
sinc
cg
pair
stabl
pair
distribut
five
mismatch
throughout
almost
alway
result
loss
knockdown
low
concentr
oligo
sometim
use
specif
control
five
mismatch
one
end
oligo
still
contigu
complementari
base
base
would
retain
consider
antisens
activ
check
morpholino
target
sequenc
databas
find
partial
homolog
region
follow
rule
thumb
like
homolog
wo
nt
caus
offtarget
knockdown
lead
troubl
import
consid
distribut
mismatch
addit
factor
consid
analyz
partial
homolog
target
lose
cg
pair
due
mismatch
impact
oligo
activ
lose
pair
three
hbond
compar
two
mismatch
sometim
form
gt
pair
contribut
half
stabil
pair
aboulela
et
al
sinc
unmodifi
morpholino
diffus
cytosol
nucleu
deliveri
morpholino
cytosol
suffici
ensur
entri
nucleu
morco
howev
unmodifi
morpholino
readili
diffus
across
plasma
membran
cell
type
unmodifi
morpholino
ad
cell
cultur
without
deliveri
reagent
high
concentr
long
exposur
time
must
use
achiev
minim
deliveri
sazani
et
al
demonstr
plasma
membran
imperm
morpholino
microinject
one
blastomer
xenopu
laevi
embryo
twocel
stage
daughter
cell
inject
cell
contain
morpholino
activ
daughter
cell
uninject
cell
contain
detect
morpholino
activ
nutt
et
al
report
particular
cell
type
tissu
explant
take
experiment
use
concentr
unmodifi
morpholino
cell
type
includ
epitheli
cell
mous
embryo
pancreat
explant
cultur
prasadan
et
al
liver
cell
mous
embryo
liver
explant
monga
et
al
use
engin
mous
stabli
integr
green
fluoresc
protein
gfp
upregul
splicecorrect
report
system
see
upregul
system
sazani
show
scant
uptak
unmodifi
morpholino
tissu
blood
adult
mice
sazani
et
al
scrape
load
morpholino
adher
cell
cultur
earli
method
introduc
morpholino
cultur
cell
partridg
et
al
adher
cell
gentli
lift
bottom
well
use
soft
rubber
scraper
cell
becom
transient
permeabl
allow
morpholino
diffus
cytosol
medium
techniqu
deliv
oligo
cell
cultur
reproduc
depend
techniqu
experiment
method
fallen
favor
reproduc
techniqu
produc
homogen
deliveri
develop
microinject
morpholino
earli
embryo
wide
use
techniqu
knock
gene
express
microinject
introduc
morpholino
directli
cytosol
cytoplasm
apport
daughter
cell
cell
divis
daughter
cell
contain
morpholino
embryo
xenopu
sp
strong
permeabl
barrier
prevent
appreci
leakag
daughter
uninject
cell
nutt
et
al
embryo
zebrafish
danio
rerio
allow
diffus
morpholino
cell
first
cell
divis
good
model
morpholino
diffus
zebrafish
embryo
see
kimmel
law
b
electropor
becom
standard
method
deliveri
morpholino
chick
embryo
ko
et
al
especi
studi
neural
tube
develop
tucker
electropor
also
use
deliv
morpholino
embryo
includ
mice
mellitz
et
al
brain
develop
rat
takahashi
et
al
zebrafish
cerda
et
al
clip
fin
zebrafish
thummel
et
al
cell
cultur
jubin
uncharg
morpholino
electropor
electropor
procedur
make
cell
transient
permeabl
morpholino
diffus
across
plasma
membran
investig
prefer
use
morpholino
conjug
ionic
fluoresc
tag
electropor
endoport
reagent
develop
deliv
morpholino
oligo
conveni
reproduc
cytosol
cultur
cell
endocytot
pathway
endoport
amphiphil
peptid
becom
cation
low
ph
cultur
medium
endoport
uncharg
stick
surfac
cell
upon
endocytosi
endoport
proton
acid
endosom
permeabil
endosom
membran
releas
endosom
content
cytoplasm
morpholino
coendocytos
membraneassoci
endoport
releas
cytoplasm
endosom
permeabil
summerton
endoport
allow
simultan
deliveri
multipl
morpholino
concentr
morpholino
vari
independ
endoport
concentr
allow
doserespons
antisens
studi
hold
deliveri
reagent
concentr
constant
cell
treat
carboxyfluorescein
morpholino
endoport
gave
transfect
effici
human
amnionderiv
wish
cell
human
myometri
cell
assay
confoc
microscopi
tysoncapp
europefinn
though
concentr
low
detect
fluoresc
might
still
suffici
measur
antisens
activ
endoport
use
success
tradit
hardtotransfect
cell
cardiomyocyt
masaki
et
al
work
well
unmodifi
morpholino
carboxyfluorescein
morpholino
best
deliveri
achiev
lissamin
morpholino
st
knuth
unpub
observ
endoport
commerci
avail
neat
dmso
lesseffect
aqueou
formul
cell
sensit
dmso
recommend
concentr
endoport
achiev
use
mm
endoport
solut
per
millilit
cell
cultur
concentr
give
good
deliveri
without
toxic
mani
cell
type
howev
cell
type
vari
toler
endoport
cell
toler
higher
exposur
cell
harm
endoport
solut
tri
endoport
new
cell
type
prudent
initi
test
rang
endoport
concentr
eg
assess
deliveri
check
toler
cell
reagent
morpholino
sometim
deliv
use
cation
deliveri
reagent
ethoxyl
polyethylenimin
epei
lipofectamin
howev
sinc
morpholino
charg
form
electrostat
complex
cation
deliveri
reagent
without
complex
morpholino
poorli
deliv
cytosol
treat
cell
cultur
overcom
limit
morpholino
anneal
complementari
partial
complementari
strand
anion
nucleic
acid
special
deliveri
oligo
heteroduplex
morpholino
partial
complementari
dna
deliv
complex
epei
morco
special
deliveri
oligo
design
replac
scrape
load
adher
cell
also
use
cell
suspens
special
deliveri
oligo
provid
homogen
deliveri
scrape
load
mani
studi
publish
use
howev
sever
problem
inher
system
epei
somewhat
toxic
cell
concentr
ratio
heteroduplex
epei
fix
singl
oligo
sequenc
deliv
effect
concentr
one
time
complex
procedur
must
done
prior
deliveri
add
complex
variabl
experi
special
deliveri
oligo
made
follow
fairli
simpl
protocol
longer
avail
commerci
pair
heteroduplex
approach
mostli
supplant
endoport
simpler
use
versatil
effect
less
toxic
cell
type
cellpenetr
peptid
coval
conjug
morpholino
enhanc
cytosol
deliveri
morpholino
cell
cultur
neuman
et
al
vivo
kinney
et
al
neuman
et
al
tripathi
et
al
publish
research
describ
morpholinopeptid
conjug
use
argininerich
peptid
neuman
et
al
dea
et
al
kinney
et
al
nelson
et
al
mcclorey
et
al
conjug
argininerich
peptid
alter
specif
target
affin
toxic
morpholino
nelson
et
al
due
high
densiti
cation
charg
peptid
moieti
morpholino
conjug
argininerich
peptid
associ
subcellular
structur
outer
cell
surfac
properti
might
lead
falseposit
artifact
assess
deliveri
arginineconjug
peptid
fluorescencebas
method
fluoresc
microscopi
fluorometri
flow
cytometri
determin
concentr
intern
conjug
use
fluorescencebas
method
membraneassoci
conjug
remov
order
avoid
overestim
trypsin
treatment
effect
elimin
bind
morpholinopeptid
conjug
outsid
cell
moulton
moulton
exampl
peptidemorpholino
conjug
target
use
treatment
transgen
mous
model
spinal
muscular
atrophi
carri
human
gene
use
morpholino
target
exon
human
gene
conjug
argininerich
cellpenetr
peptid
spinal
muscular
atrophi
sever
neuromuscular
diseas
human
caus
loss
function
protein
fortun
gene
duplic
form
gene
mutant
splice
site
prevent
express
splice
redirect
wildsplic
site
block
splice
silenc
regulatori
motif
intron
protein
express
compens
lack
administ
sma
model
mous
pup
postnat
day
facial
vein
inject
median
surviv
time
increas
day
compar
day
untreat
salinetr
mice
muscl
strength
abil
respond
headdown
posit
slope
turn
around
neg
geotaxi
assay
significantli
improv
treatment
compar
untreat
standard
morpholinotr
pup
day
dose
given
postnat
day
surviv
improv
median
day
dose
day
dose
detect
toxic
two
dose
scrambledsequ
improv
surviv
two
dose
morpholino
without
cellpenetr
peptid
improv
surviv
median
day
dose
mice
given
two
dose
gain
weight
faster
untreat
sma
mice
fast
wild
type
hindlimb
strength
perform
neg
geotaxi
assay
twodos
mice
greatli
improv
untreat
sma
mice
dosedepend
increas
transgen
human
sma
protein
fulllength
transgen
transcript
measur
improv
neural
morpholog
observ
treatment
dose
adult
mice
carri
human
transgen
twice
day
apart
tailvein
inject
mgkg
result
signific
upregul
fulllength
human
transgen
threefold
transgen
product
accumul
day
postadministr
muscl
treat
mice
rel
salinetr
control
hammond
et
al
conjug
two
morpholino
oligo
target
differ
transcript
singl
cellpenetr
peptid
success
deliv
antisens
activ
cell
cultur
dmd
model
mdx
mice
intramuscular
inject
bispecif
conjug
propos
therapeut
strategi
decreas
toxic
due
cellpenetr
peptid
compon
conjug
deliv
oligo
per
peptid
shabanpoor
et
al
conjug
morpholino
nitrogen
morpholino
oligo
eighttip
dendrim
guanidinium
moieti
tip
produc
vivomorpholino
oligo
design
enhanc
vivo
deliveri
base
argininerich
cellpenetr
peptid
carri
guanidinium
moieti
arginin
side
chain
dendrimer
deliveri
moieti
toxic
dose
vivomorpholino
limit
vivo
amount
toler
anim
iv
administr
ld
mice
mgkg
jiang
per
comm
vivo
dose
antisens
work
rare
exceed
mgkg
toxic
mice
involv
chang
blood
viscos
ferguson
et
al
vivomorpholino
effect
mani
tissu
includ
smooth
skelet
muscl
especi
effect
enter
liver
kidney
moder
uptak
seen
cardiomyocyt
still
use
wu
et
al
vivomorpholino
cross
bloodbrain
barrier
effect
effect
brain
administ
cerebrospin
fluid
instanc
intracerebroventricular
infus
inject
reissner
et
al
dose
report
paper
nmol
report
pmol
ie
high
k
reissner
per
comm
local
inject
keep
overal
dose
lower
produc
antisens
effect
particular
tissu
kumar
et
al
vivomorpholino
also
effect
cell
cultur
system
et
al
avoid
offtarget
knockdown
lowest
concentr
morpholino
produc
desir
knockdown
determin
deliv
morpholino
cell
cultur
use
endoport
start
morpholino
concentr
fluoresc
deliveri
assay
function
experi
increas
chanc
fluoresc
visibl
cytosol
first
function
experi
produc
measur
result
morpholino
concentr
might
caus
nonspecif
effect
due
interact
nontarget
gene
function
assay
perform
use
rang
morpholino
concentr
determin
lowest
morpholino
concentr
produc
measur
result
allow
one
subsequ
minim
offtarget
knockdown
conserv
oligo
effect
morpholino
concentr
cultur
medium
knockdown
experi
typic
rang
oligo
sometim
deliv
togeth
enhanc
effect
pair
nonoverlap
translationblock
morpholino
target
mrna
often
dosesynergist
use
simultan
order
decreas
concentr
requir
knockdown
ekker
larson
pair
oligo
simultan
introduc
cell
sometim
effect
much
lower
concentr
either
oligo
alon
oligo
individu
toxic
zebrafish
use
combin
concentr
toxic
threshold
might
elicit
desir
phenotyp
without
toxic
effici
splicemodif
increas
block
donor
acceptor
splice
site
flank
singl
exon
pa
morco
unpub
observ
target
sever
exon
simultan
effect
way
deplet
wildsplic
mrna
draper
et
al
design
oligo
intend
codeliveri
check
complementar
oligo
may
caus
form
morpholino
heterodim
lose
activ
see
troubleshoot
oligo
activ
decreas
pair
oligo
best
begin
set
morpholino
experi
cell
line
confirm
optim
deliveri
experiment
problem
involv
morpholino
cell
cultur
due
insuffici
deliveri
oligo
solv
optim
deliveri
particular
type
cell
use
check
whether
good
cytosol
deliveri
achiev
use
fluoresc
standard
control
oligo
fluoresc
surrog
start
use
custommad
morpholino
usual
effici
use
time
resourc
fluoresc
measur
fluoresc
microscopi
flow
cytometri
fluorometri
fluoresc
microscopi
distinguish
cytosol
nuclear
fluoresc
indic
success
deliveri
fluoresc
morpholino
endosom
surfacebound
fluoresc
contribut
antisens
activ
fluoresc
microscop
fluoresc
label
marker
morpholino
dextran
requir
reliabl
deliveri
assay
use
fluorescein
dextran
carboxyfluorescein
standard
morpholino
control
use
expens
custommad
morpholino
produc
reliabl
uptak
assay
reduc
cost
deliveri
live
cell
may
conveni
observ
use
invert
epifluoresc
microscop
fix
cell
lead
fals
posit
deliveri
due
permeabil
plasma
membran
releas
oligo
endosom
fixat
use
object
higher
numer
apertur
increas
amount
light
gather
cell
help
reveal
dim
fluoresc
diffus
fluoresc
seen
throughout
cytosol
cell
morpholino
deliv
success
bright
punctat
spot
like
label
oligo
trap
endosom
punctat
fluoresc
indic
deliveri
preclud
either
diffus
fluoresc
import
signal
determin
whether
deliveri
succeed
deliveri
endoport
start
assay
rang
endoport
concentr
deliveri
efficaci
cell
toler
see
basic
protocol
tri
concentr
endoport
select
cell
cultur
endoport
deliveri
antisens
activ
detect
use
littl
morpholino
howev
although
antisens
activ
achiev
morpholino
concentr
produc
detect
fluoresc
proofofdeliveri
experi
use
microscopi
requir
detect
fluoresc
accumul
enough
fluoresc
microscopi
concentr
morpholino
need
endoport
label
morpholino
left
cell
overnight
allow
time
endocytot
uptak
accumul
deliveri
success
morpholino
target
translat
splice
work
design
decreas
protein
concentr
shift
rtpcr
product
mass
respect
measur
success
deliveri
might
also
indic
phenotyp
effect
decreas
target
enzym
activ
hayashi
et
al
chang
morpholog
ekker
howev
assay
phenotyp
effect
becom
problemat
expect
chang
phenotyp
occur
antisens
activ
separ
assess
level
protein
concentr
mrna
mass
experiment
abl
discern
whether
oligo
fail
reach
interact
target
mrna
produc
knockdown
spliceblock
knockdown
spliceblock
success
caus
expect
phenotyp
chang
activ
translationblock
morpholino
assay
use
immunoblot
howev
morpholino
halt
new
translat
caus
degrad
exist
protein
therefor
take
time
morpholino
treatment
immunoblot
show
evid
knockdown
time
requir
vari
halflif
protein
well
effici
knockdown
antibodi
avail
protein
product
target
mrna
translat
block
indirect
assay
chang
phenotyp
embryo
must
sometim
use
assess
effect
translat
block
morpholino
phenocopi
mimic
phenotyp
mani
known
mutat
affect
morpholog
develop
sometim
reveal
new
phenotyp
conceal
express
compens
mutant
embryo
phenotyp
modifi
morpholino
treatment
known
morphant
ekker
case
enzymat
activ
target
protein
assay
hayashi
et
al
enzym
activ
assay
may
serv
assay
morpholino
activ
although
must
delay
applic
morpholino
enzym
activ
assay
allow
degrad
preexist
protein
see
also
discuss
complement
troubleshoot
effect
morpholino
target
rna
stabil
vari
sequenc
target
mrna
concentr
morpholinotr
cell
may
decreas
unchang
increas
rel
untreat
cell
chang
mrna
concentr
might
due
chang
secondari
structur
mrna
bind
morpholino
therebi
alter
avail
mrna
nucleolyt
degrad
consequ
mrna
assay
northern
blot
quantit
pcr
suitabl
assay
activ
translationblock
morpholino
block
splice
chang
mass
mrna
produc
rtpcr
appropri
choic
primer
follow
gel
electrophoresi
determin
fragment
size
good
molecular
method
detect
activ
spliceblock
morpholino
howev
import
keep
mind
predict
certainti
whether
spliceblock
morpholino
caus
exon
delet
common
intron
insert
activ
cryptic
splice
site
caus
partial
insert
delet
multipl
exon
skip
cryptic
site
might
redirect
splice
fraction
target
premrna
popul
splice
block
produc
mixtur
rtpcr
product
mass
draper
et
al
detect
chang
best
use
primer
target
two
exon
flank
closest
includ
exon
abut
morpholino
splice
junction
though
reveal
multiexon
skip
requir
widelyspac
primer
target
splice
junction
intern
exon
ie
first
last
like
caus
exon
delet
primer
chosen
exon
delet
occur
rtpcr
product
larg
enough
detect
easili
gel
one
hundr
sever
hundr
base
mean
system
splice
blocker
target
rtpcr
primer
target
exon
exon
order
detect
either
intron
insert
unusu
exon
delet
common
larg
intron
insert
matur
mrna
pcr
polymeras
might
reliabl
progress
way
primer
site
exon
case
exchang
one
exon
primer
intron
primer
reveal
presenc
insert
exon
first
last
splice
junction
mrna
target
usual
result
intron
insert
instead
exon
delet
howev
target
first
splice
junction
might
activ
cryptic
splice
site
result
delet
end
first
exon
inclus
fragment
first
intron
target
last
exon
intron
insert
like
outcom
consensu
sequenc
splice
acceptor
complex
splice
donor
less
like
last
intron
exon
contain
nearconsensu
cryptic
splice
acceptor
assay
activ
spliceblock
morpholino
molecular
level
use
rtpcr
import
compar
expect
size
rtpcr
product
splice
modif
size
rtpcr
product
produc
untreat
cell
organ
easiest
detect
spliceblock
rtpcr
product
would
half
twice
size
nativespl
product
exon
delet
intron
insert
respect
real
system
usual
wo
nt
allow
tidi
result
necessari
chang
mass
clearli
visibl
gel
eg
chang
mass
difficult
detect
sequenc
splicemodifi
rna
reveal
small
chang
hard
resolv
gel
fidel
replic
problem
rtpcr
best
design
shorter
rtpcr
product
els
equal
mean
knockdown
exon
target
primer
exon
near
junction
intron
exon
near
junction
intron
would
best
choic
howev
els
equal
sinc
fragment
larg
enough
clearli
visibl
prudent
move
primer
flank
exon
possibl
primer
amplifi
rtpcr
product
length
hundr
base
ensur
fulllength
replic
visibl
band
splice
modif
caus
downstream
frameshift
inclus
intron
sequenc
matur
messeng
either
result
caus
rang
complic
effect
includ
truncat
protein
product
appear
infram
stop
codon
translat
suppress
appear
mirna
target
site
degrad
suppress
messeng
sirna
mirna
activ
nonsensemedi
mrna
decay
splice
modif
may
may
caus
chang
detect
immunochem
assay
elisa
immunoblot
sinc
conform
modifi
protein
around
antigen
site
may
may
chang
splice
modif
larg
insert
delet
might
result
loss
antibodi
bind
least
signific
shift
band
posit
western
blot
small
insert
delet
could
difficult
detect
target
caus
frameshift
usual
facilit
detect
oligo
activ
immunochem
method
especi
nonsensemedi
decay
decreas
protein
express
splicemodifi
rna
possibl
insert
intron
delet
exon
caus
protein
product
lose
function
far
certain
activ
site
protein
known
exon
encod
activ
site
target
loss
function
like
howev
activ
site
known
spliceblock
might
chang
protein
activ
protein
might
made
retain
conform
activ
site
even
though
insert
delet
polypeptid
moieti
differ
part
protein
mean
look
phenotyp
chang
embryo
assay
enzym
activ
often
inadequ
assess
spliceblock
activ
morpholino
also
mean
rtpcr
use
tool
confirm
splice
block
activ
one
independ
assay
protein
function
conclud
target
gene
requir
biolog
process
success
spliceblock
may
alter
activ
protein
process
assay
antisens
activ
knock
protein
lead
fals
posit
toxic
caus
decreas
gene
express
misinterpret
target
gene
knockdown
unless
care
control
use
address
problem
provid
increas
signaltonois
ratio
antisens
activ
assay
ryzard
kole
group
develop
set
signal
upregul
report
system
base
splice
modif
system
use
mutat
human
creat
new
splice
site
caus
thalassemia
splicemut
stop
codon
infram
mrna
well
frameshift
downstream
code
region
mutant
site
block
stop
codon
splice
correct
read
frame
restor
construct
coupl
mutat
luciferas
gfp
engin
particular
interest
hela
cell
line
schmajuk
et
al
express
luciferas
mutant
splice
site
spliceblock
control
oligo
sazani
mous
sazani
et
al
express
gfp
spliceblock
appropri
oligo
oligo
use
target
mrna
parallel
experi
done
use
neg
control
oligo
neg
control
oligo
includ
standard
control
oligo
invert
oligo
specif
control
oligo
also
sometim
use
neg
control
neg
control
show
effect
observ
antisens
experi
due
sequenc
target
oligo
backbon
chemistri
morpholino
cytosol
deliveri
method
use
standard
control
morpholino
sequenc
cctcctacctcagttacaatttata
use
mani
organ
neg
control
sequenc
without
trigger
offtarget
nonantisens
effect
neg
control
produc
toxic
teratogen
effect
even
administ
consider
higher
concentr
typic
use
specif
knockdown
experi
customsequ
control
oligo
risk
interact
offtarget
rna
contrast
standard
control
establish
histori
inact
reliabl
choic
neg
control
oligo
standard
control
morpholino
design
spliceblock
mutant
splice
site
use
upregul
report
system
neg
control
oligo
need
relat
custommad
target
oligo
term
base
composit
invert
oligo
good
choic
sequenc
invert
base
sequenc
target
oligo
sequenc
revers
orient
ie
acggtgc
would
becom
cgtggca
advantag
invert
scrambl
sequenc
invert
sequenc
conveni
gener
simpl
algorithm
cg
content
g
content
selfcomplementar
target
oligo
howev
alway
risk
custommad
oligo
oligo
may
interact
unintend
rna
sens
morpholino
sometim
caus
increas
concentr
mrna
target
antisens
oligo
pa
morco
unpub
observ
thu
sens
sequenc
good
choic
negativecontrol
morpholino
offtarget
knockdown
antisens
molecul
increas
increas
concentr
oligo
use
defin
effect
specif
concentr
window
target
oligo
use
target
oligo
within
effect
specif
concentr
rang
decreas
chanc
caus
experiment
artifact
interact
offtarget
rna
control
oligo
nearli
sequenc
target
oligo
five
mismatch
base
distribut
sequenc
mismatch
distribut
fairli
evenli
oligo
start
base
end
possibl
mismatch
form
exchang
c
g
g
c
sinc
mismatch
disrupt
format
three
hydrogen
bond
per
base
pair
ideal
target
oligo
use
near
lowest
concentr
produc
discern
effect
oligo
use
concentr
produc
effect
howev
customsequ
control
oligo
possibl
oligo
interact
untarget
rna
trigger
offtarget
effect
oligo
target
highcopynumb
transcript
requir
rel
high
morpholino
concentr
knockdown
mispair
oligo
interact
lowcopynumb
transcript
mispair
oligo
might
caus
effect
even
concentr
concentr
target
oligo
becom
effect
oligo
use
experi
determin
effect
specif
window
concentr
target
oligo
concentr
rang
onset
measur
activ
target
oligo
onset
measur
activ
oligo
definit
effect
specif
concentr
rang
base
morpholino
evolv
trial
error
origin
specif
control
recommend
oligo
sometim
measur
decreas
target
protein
concentr
concentr
low
enough
correspond
target
oligo
becom
effect
wide
enough
effect
specif
concentr
rang
consist
use
mani
investig
use
oligo
neg
control
intend
purpos
assum
ad
mismatch
creat
much
complementar
import
offtarget
mrna
trigger
offtarget
knockdown
oligo
usual
behav
neg
control
use
concentr
low
enough
target
oligo
becom
effect
howev
oligo
intend
specif
control
show
target
oligo
use
effect
specif
rang
demonstr
specif
target
oligo
target
oligo
control
oligo
true
neg
control
oligo
standard
control
use
concentr
parallel
treatment
neg
control
oligo
produc
result
target
oligo
produc
differ
result
experi
indic
target
oligo
use
within
effect
specif
concentr
rang
appear
effect
due
interact
target
rna
control
oligo
suggest
concentr
target
oligo
might
also
interact
offtarget
rna
fivemispair
oligo
success
defin
effectiveandspecif
concentr
rang
experi
two
nonoverlap
oligo
becom
prefer
specif
control
anoth
strategi
show
effect
translationblock
morpholino
due
knockdown
target
mrna
use
second
oligo
target
differ
nonoverlap
site
utr
target
mrna
second
oligo
effect
cell
organ
first
support
hypothesi
effect
observ
due
knockdown
target
gene
differ
oligo
usual
differ
valu
match
phenotyp
might
requir
differ
dose
two
oligo
one
oligo
elicit
effect
copi
like
due
offtarget
rna
interact
addit
nonoverlap
oligo
might
need
support
specif
morpholino
target
splice
donor
site
produc
result
morpholino
target
splice
acceptor
exon
support
hypothesi
effect
observ
due
excis
target
exon
howev
failur
two
oligo
produc
result
may
due
activ
cryptic
splice
site
unexpect
splice
outcom
one
oligo
interfer
translat
regulatori
site
unexpect
rna
also
possibl
sourc
phenotyp
chang
strong
proof
specif
involv
use
rescu
mrna
rescu
mrna
code
protein
target
morpholino
knockdown
modifi
utr
target
morpholino
experi
rescu
mrna
morpholino
deliv
cytosol
togeth
codeliv
rescu
mrna
morpholino
produc
wildtyp
phenotyp
untreat
cell
organ
support
hypothesi
morphant
phenotyp
elicit
morpholino
alon
due
interact
target
rna
unfortun
mrna
rescu
experi
work
gene
use
embryo
time
onset
translat
gene
crucial
develop
earli
onset
translat
result
coinject
morpholino
rescu
mrna
earli
zygot
may
alter
development
process
embryo
never
recapitul
wildtyp
phenotyp
furthermor
locat
gene
express
often
crucial
develop
oocyt
microinject
caus
rescu
mrna
present
cell
embryo
degrad
dilut
growth
express
plasmid
carri
cdna
control
endogen
promot
could
avoid
extop
express
rescu
mrna
sever
option
modif
attach
end
morpholino
commerci
avail
carboxyfluorescein
lissamin
primari
amin
commonli
use
option
group
usual
ad
secondari
amin
end
oligo
assum
modif
unless
explicitli
declar
modif
fluorophor
biotin
attach
morpholino
flexibl
spacer
length
spacer
chosen
base
antisens
activ
studi
ensur
fluorophor
would
interfer
bind
morpholino
target
rna
sequenc
primari
amin
modif
includ
short
spacer
two
methylen
carboxyfluorescein
greenemit
fluorophor
chosen
among
fluorescein
good
chemic
stabil
photost
better
mani
fluorescein
fluorescein
subject
photobleach
carboxyfluorescein
expos
intens
light
unnecessarili
excit
wavelength
carboxyfluorescein
morpholino
water
nm
emiss
wavelength
nm
carboxyfluorescein
two
neg
charg
neutral
ph
lissamin
redemit
sulforhodamin
b
excit
wavelength
lissamin
morpholino
water
nm
emiss
wavelength
nm
lissamin
zwitterion
neutral
ph
one
posit
one
neg
charg
ad
lissamin
morpholino
increas
deliveri
effici
endoport
ad
lissamin
morpholino
decreas
aqueou
solubl
therefor
recommend
use
carboxyfluorescein
tag
fluorochrom
need
especi
morpholino
sequenc
rel
high
g
content
g
gene
tool
blue
blueemit
fluoresc
tag
pyren
core
three
morpholinosulfamid
group
excit
wavelength
fluor
morpholino
aqueou
solut
nm
emiss
nm
imag
dapi
filter
set
set
optim
gene
tool
blue
concentr
threshold
detect
rel
high
optim
filter
set
fluor
still
less
bright
carboxyfluorescein
lissamin
morpholino
may
modifi
primari
amin
provid
reactiv
site
attach
moieti
oligo
unmodifi
morpholino
secondari
amin
end
pk
primari
amin
pk
provid
reactiv
site
primari
amin
attach
end
oligo
convert
amin
morpholin
ring
tertiari
amin
consequ
attach
short
spacer
tether
new
primari
amin
primari
amin
attach
end
oligo
secondari
amin
acetyl
reagent
ad
react
primari
amin
react
end
oligo
react
primari
amin
derivat
reagent
prudent
includ
addit
short
spacer
prevent
steric
hindranc
moieti
ad
morpholino
morpholino
stock
solut
distil
water
kept
steril
autoclav
use
water
contain
diethylpyrocarbon
depc
morpholino
stock
solut
dissolv
buffer
ringer
solut
danieau
buffer
caus
problem
later
stock
solut
must
reconcentr
sinc
lyophil
difficult
buffer
also
morpholino
substanti
solubl
distil
water
isoton
salt
solut
easier
interpret
malditof
spectrum
morpholino
salt
present
solut
morpholino
water
concentr
lyophil
freezedri
lyophil
morpholino
water
produc
fluffi
solid
tremend
surfac
area
dissolv
fairli
readili
sequenc
good
solubl
properti
dissolut
morpholino
concentr
speedvac
may
difficult
imposs
least
requir
patienc
autoclav
use
speedvac
morpholino
recommend
morpholino
degrad
nucleolyt
enzym
solut
dna
rna
normal
kept
ice
experi
prevent
nucleolyt
degrad
concern
morpholino
howev
morpholino
solut
low
enough
solubl
ice
solut
may
caus
loss
activ
due
oligo
aggreg
come
solut
therefor
ice
morpholino
solut
unnecessari
caus
problem
morpholino
kept
room
temperatur
experi
morpholino
affin
plastic
passag
dilut
submicromolar
solut
plastic
contain
may
caus
appreci
decreas
activ
similarli
filter
steril
may
caus
morpholino
solut
lose
activ
oligo
bind
filter
put
procedur
exposur
plastic
surfac
highconcentr
morpholino
solut
smaller
fraction
decreas
concentr
lowconcentr
morpholino
solut
therefor
exposur
plastic
surfac
requir
best
procedur
morpholino
rel
concentr
state
similarli
morpholino
store
solut
day
best
store
rel
high
concentr
mm
sinc
solut
morpholino
low
concentr
may
lose
activ
time
scale
minut
hour
dilut
made
use
morpholino
solut
less
filter
concentr
may
affect
appreci
given
larg
surfac
area
filter
oligo
bound
proport
surfac
expos
smalldiamet
filter
use
minim
oligo
loss
pall
acrodisc
ht
tuffryn
membran
filter
found
bind
less
morpholino
per
area
filter
test
je
summerton
unpub
observ
concentr
oligo
solut
measur
spectrophotometr
perform
filtrat
determin
loss
oligo
caus
procedur
morpholino
best
store
room
temperatur
morpholino
solut
lose
activ
store
frozen
due
degrad
oligo
simpli
aggreg
associ
contain
surfac
activ
usual
recov
autoclav
prior
use
fluoresc
tag
photobleach
exposur
bright
light
prolong
exposur
dim
light
alway
store
fluoresc
materi
dark
wrap
aluminum
foil
around
tube
contain
fluoresc
materi
easi
prudent
method
protect
fluorophor
fluoresc
materi
autoquench
high
concentr
decreas
light
emiss
measur
fluoresc
high
concentr
might
lead
deceiv
concentr
calcul
label
morpholino
solut
well
concentr
fluorophor
autoquench
morpholino
produc
anticip
result
sever
possibl
consid
oligo
solut
singlestrand
molecul
check
concentr
uv
spectrometri
autoclav
stock
disrupt
aggreg
deliveri
confirm
oligo
reach
cytosol
cell
antisens
activ
observ
activ
check
molecular
assay
select
activ
assay
determin
phenotyp
chang
embryo
morpholog
enzym
activ
oligo
may
success
knock
translat
modifi
splice
second
protein
may
complement
lost
activ
target
protein
therebi
confound
assay
assay
translat
block
immunoblot
splice
block
rtpcr
help
determin
whether
oligo
interact
target
deliv
suggest
subtl
reason
failur
produc
expect
phenotyp
complement
anoth
protein
feedback
upregul
also
caus
knockdown
fail
greatli
increas
transcript
target
mrna
respons
attempt
knockdown
overwhelm
abil
oligo
block
target
messeng
two
oligo
togeth
cell
may
hybrid
share
complementari
sequenc
pair
oligo
less
activ
individu
oligo
check
sequenc
complementar
sixteen
contigu
hydrogen
bond
complementar
maximum
recommend
oligo
use
togeth
cell
organ
morpholino
solut
caus
microinjector
clog
one
heat
solut
disrupt
tini
clump
min
autoclav
filtersteril
solut
although
oligo
may
lost
filter
tri
inject
higher
volum
less
concentr
solut
translationblock
morpholino
knock
express
protein
activ
reveal
delay
decreas
protein
signal
immunoblot
use
antibodi
protein
success
knockdown
also
decreas
activ
target
protein
though
assay
activ
protein
confound
complement
anoth
protein
spliceblock
morpholino
chang
mass
mrna
activ
reveal
soon
deliveri
chang
mass
rtpcr
product
produc
use
appropri
chosen
primer
assess
electrophoret
gel
success
exon
excis
also
result
delay
decreas
activ
encod
delet
exon
preexist
protein
degrad
splice
block
may
also
decreas
activ
encod
untarget
exon
target
rna
due
frameshift
insert
stop
codon
chang
tertiari
structur
assess
differ
phenotyp
compar
mutant
zebrafish
embryo
morpholino
knockdown
gene
wildtyp
zebrafish
embryo
lab
studi
combin
metaanalysi
publish
report
found
less
mutant
morphlino
knockdown
share
phenotyp
chang
wildtyp
phenotyp
comparison
led
paper
assert
differ
phenotyp
may
due
offtarget
effect
morpholino
morpholino
consid
give
valid
data
phenocopi
mutant
author
conclud
would
suggest
broader
communitywid
editori
guidelin
requir
observ
moinduc
phenotyp
valid
embryo
bear
mutat
gene
mo
could
reliabl
appli
subsequ
function
studi
kok
et
al
rigor
proof
specif
morpholino
provid
half
paper
use
metaanalysi
mani
mutant
paper
hypomorph
blum
et
al
one
case
megamindtarget
morpholino
found
give
phenotyp
even
talenengin
fish
line
morpholino
bind
sequenc
remov
dna
megamind
locu
howev
morpholino
use
excess
dose
ng
per
embryo
kok
et
al
figur
morco
et
al
nevertheless
call
verifi
morphant
phenotyp
mutant
led
demand
review
mutant
confirm
morpholino
studi
slow
public
data
ad
consider
expens
releas
new
find
appropri
soon
kok
et
al
paper
taleninduc
mutant
compar
morphant
gene
express
chang
gene
found
mutant
morphant
reveal
like
compensatori
gene
express
conceal
protein
function
mutant
knockdown
rossi
et
al
morpholino
gave
rise
sever
vascular
tube
format
phenotyp
seen
mutant
shown
carri
sever
null
mutat
fish
mutat
inject
morpholino
surprisingli
fish
reduc
incid
vascular
phenotyp
compar
wildtyp
fish
inject
morpholino
indic
mutant
fish
less
sensit
morpholino
wildtyp
fish
first
hint
chang
mutant
fish
might
conceal
phenotyp
morpholino
induc
wildtyp
fish
vascular
defect
phenotyp
associ
morpholino
recapitul
experi
use
crispr
interfer
crispri
inhibit
express
comparison
protein
concentr
singl
shot
liquid
chromatographytandem
mass
spectrometri
lcmsm
found
one
protein
strongli
upregul
mutant
compar
morphant
protein
share
import
function
structur
emi
domain
might
compens
loss
mutant
rna
sequenc
qpcr
found
upregul
mutant
embryo
knock
morpholino
crispri
coinject
morpholino
mrna
abl
rescu
circulatori
phenotyp
similarli
upregul
vegfab
found
vegfaa
mutant
vegfaa
morphant
instead
morpholino
offtarget
effect
compens
loss
transcript
mutant
may
underli
mani
mutantmorph
phenotyp
discrep
inde
one
identifi
dose
mo
effect
mutant
embryo
caus
clear
vascular
defect
wt
indic
morphant
phenotyp
due
offtarget
effect
rossi
et
al
compens
mutant
conceal
function
gene
function
reveal
knockdown
technolog
reason
insist
morpholino
phenotyp
must
copi
mutant
public
requir
observ
moinduc
phenotyp
valid
embryo
bear
mutat
gene
exclud
valuabl
insight
literatur
mistrust
morpholino
data
engend
kok
paper
may
even
lead
grantreview
committe
inappropri
block
consider
wellcraft
studi
reli
primarili
knockdown
technolog
reveal
gene
function
morpholino
act
rna
induc
mutat
directli
alter
dna
loss
gene
function
occur
differ
time
scale
differ
outcom
expect
strength
approach
exploit
morpholino
deliv
cytosol
cell
preexist
protein
alter
morpholino
translationblock
oligo
mean
even
translat
protein
immedi
complet
halt
morpholino
deliveri
assay
protein
concentr
immedi
reveal
success
knockdown
least
part
exist
protein
must
degrad
knockdown
evid
immunoblot
similarli
although
spliceblock
oligo
may
caus
rapid
chang
mass
rtpcr
product
protein
produc
prior
splice
block
persist
cell
degrad
deliveri
system
use
endocytot
uptak
endoport
special
deliveri
increas
lag
start
deliveri
appear
knockdown
spliceblock
signal
overnight
wait
gener
suffici
allow
endocytot
uptak
embryon
studi
presenc
matern
transcript
zygot
may
delay
loss
protein
activ
spliceblock
morpholino
use
although
splice
blocker
modifi
splice
premrna
transcrib
zygot
matern
transcript
alreadi
splice
onset
zygot
transcript
express
unmodifi
form
translationblock
block
matern
zygot
transcript
thu
might
provid
rapid
knockdown
splice
blocker
translat
protein
block
morpholino
exist
protein
cell
persist
broken
deliveri
cell
grow
divid
concentr
morpholino
oligo
cytoplasm
decreas
due
dilut
morpholino
bind
rna
target
protect
bind
site
nucleas
singlestrand
antisens
slowli
releas
rna
footprint
process
morpholino
use
knock
gene
highli
transcrib
code
unusu
abund
stabl
protein
redeliveri
oligo
may
requir
signific
decreas
protein
level
detect
immunoblot
knockdown
protein
rapid
turnov
transcript
factor
easili
measur
hr
stabl
protein
requir
longer
treatment
see
knockdown
initi
treatment
morpholino
start
day
redeliveri
day
usual
suffic
produc
clear
knockdown
stabl
protein
day
howev
attempt
block
translat
actin
far
fail
produc
decreas
actin
level
immunoblot
suggest
morpholino
knock
abund
protein
pa
morco
unpub
observ
